老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Bio Blast Pharma

11.50
0.0000
成交量：- -
成交額：- -
市值：482.87萬
市盈率：-1.44
高：11.50
開：11.50
低：11.50
收：11.50
52周最高：30.00
52周最低：6.19
股本：41.99萬
流通股本：25.59萬
量比：- -
換手率：- -
股息：- -
股息率：- -
每股收益(TTM):-7.9626
每股收益(LYR):-14.3528
淨資產收益率：--
總資產收益率：--
市淨率：3.10
市盈率(LYR):-0.80

資料載入中...

總覽公司新聞資訊公告
2021/06/04

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/30

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/10

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/02/09

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/04/30

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/01/31

SEC問詢函

CORRESP [Cover] - Correspondence
2020/01/31

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/01/23

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/09/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2019/07/05

SEC問詢函

CORRESP [Cover] - Correspondence
2019/03/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多